HLA-DQ Heterodimers in Hematopoietic Cell Transplantation

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2022 Mar 10

PMID 35271697

Authors

Effie W Petersdorf

Mats Bengtsson

Mary Horowitz

Caroline McKallor

Stephen R Spellman

Eric Spierings

Ted A Gooley

Phil Stevenson

Affiliations

Soon will be listed here.

Abstract

HLA-DQ heterodimers increase the susceptibility to autoimmune diseases, but their role in hematopoietic cell transplantation is unknown. We tested the hypothesis that outcome after HLA-matched and HLA-DQ-mismatched hematopoietic cell transplantation is influenced by HLA-DQ heterodimers. Heterodimers were defined in 5164 HLA-matched and 520 HLA-DQ-mismatched patients and their transplant donors according to well-established crystallographic criteria. Group 1 (G1) heterodimers are any DQA1*02/03/04/05/06α paired with any DQB1*02/03/04β. Group 2 (G2) heterodimers are DQA1*01α paired with any DQB1*05/06β. Multivariable models identified significantly higher relapse risk in G1G2 and G2G2 compared with G1G1 HLA-matched patients with malignant disease; risk increased with an increasing number of G2 molecules. In HLA-DQ-mismatched transplantation for malignant diseases, matching or mismatching for G2 increased relapse risk. G2 lowered disease-free survival after both HLA-matched and HLA-DQ-mismatched transplantation. A paradigm based on HLA-DQ heterodimers provides a functional definition of the hematopoietic cell transplantation barrier and a means to lower risks for future patients.

Citing Articles

Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation.

Chevalier M, Allain V, Gras J, Racle J, Villemonteix J, Divard G Sci Adv. 2025; 11(10):eadt3499.

PMID: 40043107 PMC: 11881896. DOI: 10.1126/sciadv.adt3499.

Understanding HLA-DQ in renal transplantation: a mini-review.

Das R, Greenspan N Front Immunol. 2025; 16:1525306.

PMID: 39975547 PMC: 11835797. DOI: 10.3389/fimmu.2025.1525306.

HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation.

Le Grand S, Villemonteix J, Daguindau E, Fort M, Caillat-Zucman S, Allain V Hemasphere. 2025; 9(2):e70088.

PMID: 39949376 PMC: 11822263. DOI: 10.1002/hem3.70088.

Novel Scoring System for Ranking Hematopoietic Stem Cell Transplantation.

Baxter-Lowe L, Wang T, Kuxhausen M, Spellman S, Maiers M, Lee S Clin Transplant. 2024; 38(11):e15478.

PMID: 39512128 PMC: 11840805. DOI: 10.1111/ctr.15478.

Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers.

Zhao L, Papadopoulos G, Skyler J, Pugliese A, Parikh H, Kwok W Diabetologia. 2024; 67(11):2481-2493.

PMID: 39354095 PMC: 11519105. DOI: 10.1007/s00125-024-06274-6.

References

Chow I, Gates T, Papadopoulos G, Moustakas A, Kolawole E, Notturno R . Discriminative T cell recognition of cross-reactive islet-antigens is associated with HLA-DQ8 transdimer-mediated autoimmune diabetes. Sci Adv. 2019; 5(8):eaaw9336. PMC: 6703875. DOI: 10.1126/sciadv.aaw9336. View

Battiwalla M, Ellis K, Li P, Pavletic S, Akpek G, Hematti P . HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2012; 18(8):1302-8. PMC: 3580851. DOI: 10.1016/j.bbmt.2012.02.011. View

Raymond C, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S . Ancient haplotypes of the HLA Class II region. Genome Res. 2005; 15(9):1250-7. PMC: 1199539. DOI: 10.1101/gr.3554305. View

Brown J, Jardetzky T, Gorga J, Stern L, Urban R, Strominger J . Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993; 364(6432):33-9. DOI: 10.1038/364033a0. View

Furst D, Muller C, Vucinic V, Bunjes D, Herr W, Gramatzki M . High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood. 2013; 122(18):3220-9. DOI: 10.1182/blood-2013-02-482547. View

Trowsdale J, Knight J . Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet. 2013; 14:301-23. PMC: 4426292. DOI: 10.1146/annurev-genom-091212-153455. View

Ollila H, Fernandez-Vina M, Mignot E . HLA-DQ allele competition in narcolepsy: a comment on Tafti et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep. 2014; 38(1):147-51. PMC: 4262948. DOI: 10.5665/sleep.4342. View

Unanue E, Turk V, Neefjes J . Variations in MHC Class II Antigen Processing and Presentation in Health and Disease. Annu Rev Immunol. 2016; 34:265-97. DOI: 10.1146/annurev-immunol-041015-055420. View

van Lummel M, Van Veelen P, Zaldumbide A, de Ru A, Janssen G, Moustakas A . Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire. J Biol Chem. 2011; 287(12):9514-24. PMC: 3308765. DOI: 10.1074/jbc.M111.313940. View

10.

van Lummel M, Buis D, Ringeling C, de Ru A, Pool J, Papadopoulos G . Epitope Stealing as a Mechanism of Dominant Protection by HLA-DQ6 in Type 1 Diabetes. Diabetes. 2019; 68(4):787-795. DOI: 10.2337/db18-0501. View

11.

Chabas D, Taheri S, Renier C, Mignot E . The genetics of narcolepsy. Annu Rev Genomics Hum Genet. 2003; 4:459-83. DOI: 10.1146/annurev.genom.4.070802.110432. View

12.

Alonso M, Navarrete C, Solana R, Torres A, Pena J, Festenstein H . Differential expression of HLA-DR and HLA-DQ antigens on normal cells of the myelomonocytic lineage. Tissue Antigens. 1985; 26(5):310-7. DOI: 10.1111/j.1399-0039.1985.tb02229.x. View

13.

Yamamoto F, Suzuki S, Mizutani A, Shigenari A, Ito S, Kametani Y . Capturing Differential Allele-Level Expression and Genotypes of All Classical HLA Loci and Haplotypes by a New Capture RNA-Seq Method. Front Immunol. 2020; 11:941. PMC: 7272581. DOI: 10.3389/fimmu.2020.00941. View

14.

Lee S, Klein J, Haagenson M, Baxter-Lowe L, Confer D, Eapen M . High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007; 110(13):4576-83. DOI: 10.1182/blood-2007-06-097386. View

15.

Silva D, Socha L, Correcha M, Petrovsky N . Elevated lymphocyte expression of CLIP is associated with type 1 diabetes and may be a useful marker of autoimmune susceptibility. Ann N Y Acad Sci. 2005; 1037:65-8. DOI: 10.1196/annals.1337.009. View

16.

Bach F, van Rood J . The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med. 1976; 295(15):806-13. DOI: 10.1056/NEJM197610072951504. View

17.

Robinson J, Halliwell J, Hayhurst J, Flicek P, Parham P, Marsh S . The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res. 2014; 43(Database issue):D423-31. PMC: 4383959. DOI: 10.1093/nar/gku1161. View

18.

Toffalori C, Zito L, Gambacorta V, Riba M, Oliveira G, Bucci G . Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation. Nat Med. 2019; 25(4):603-611. DOI: 10.1038/s41591-019-0400-z. View

19.

Fernandez-Vina M, Klein J, Haagenson M, Spellman S, Anasetti C, Noreen H . Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood. 2013; 121(22):4603-10. PMC: 3668493. DOI: 10.1182/blood-2013-02-481945. View

20.

Siebold C, Hansen B, Wyer J, Harlos K, Esnouf R, Svejgaard A . Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A. 2004; 101(7):1999-2004. PMC: 357041. DOI: 10.1073/pnas.0308458100. View